PDS Biotechnology (NASDAQ:PDSB – Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, August 14th. Analysts expect the company to announce earnings of ($0.37) per share for the quarter. PDS Biotechnology (NASDAQ:PDSB – Get Free Report) last posted its earnings results on Monday, May 15th. The company reported […]
PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 2,680,000 shares, a growth of 27.0% from the May 15th total of 2,110,000 shares. Based on an average trading volume of 693,800 shares, the days-to-cover ratio is […]
PDS Biotechnology (NASDAQ:PDSB – Get Rating) and Silverback Therapeutics (NASDAQ:SBTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. Profitability This table compares PDS Biotechnology and Silverback Therapeutics’ […]
PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating)’s stock price was down 3.9% on Monday . The stock traded as low as $6.13 and last traded at $6.33. Approximately 281,786 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 482,226 shares. The stock had previously closed at $6.59. Wall […]